FDA New, GMP Do
Clinical Phase II, III Intermediates
GMP Custom synthesis, Full Document
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
This is my R&D youtube: https://youtu.be/r5cJdXKNXHk
| LY-163443, 97581-70-9, LY-163443 Intermediate 15184-99-3, stock 551.5g, white powder, assay by HPLC 98.8%, HNMR, LCMS we supply. |
| LY-163443, 97581-70-9, LY-163443 Intermediate 97582-08-6, stock 481.6g, white powder, assay by HPLC 99.4%, HNMR, LCMS we supply. |
| LY-163443, 97581-70-9, LY-163443 Intermediate 97582-18-8, stock 548.8g, white powder, assay by HPLC 99.4%, HNMR, LCMS we supply. |
| LY-163443, 97581-70-9, LY-163443 Intermediate 97582-21-3, stock 509g, white powder, assay by HPLC 99.8%, HNMR, LCMS we supply. |
| LY-163443, 97581-70-9, LY-163443 Intermediate 97582-29-1, stock 108.1g, white powder, assay by HPLC 98.9%, HNMR, LCMS we supply. |
| LY-163443, 97581-70-9, LY-163443 Intermediate 97582-36-0, stock 388.7g, white powder, assay by HPLC 98.7%, HNMR, LCMS we supply. |
| LY-163443, 97581-70-9, LY-163443 Intermediate 14191-95-8, stock 313.8g, white powder, assay by HPLC 99.6%, HNMR, LCMS we supply. |
| LY-163443, 97581-70-9, LY-163443 Intermediate 97581-58-3, stock 310.6g, white powder, assay by HPLC 98.2%, HNMR, LCMS we supply. |
| LY-163443, 97581-70-9, LY-163443 Intermediate 97581-70-9, stock 957.9g, white powder, assay by HPLC 99.5%, HNMR, LCMS we supply. |
